Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of British Columbia

$105,000.00

Synthesis of complex natural products

FY 2014-15

Summary
This research aims to develop innovative, efficient, and environmentally responsible methods for the preparation of nitrogenous substances of current biomedical interest, and apply such techniques to the synthesis of structurally complex natural products. The underlying theme of this research is that certain transformations that had been regarded as unlikely - or even impossible - are quite feasible. Not only they may be incorporated in the total synthesis of complex natural products at an early stage, but they also permit quantum improvements in the overall route. This constitutes the chemical significance of the work. In terms of practical significance, our targets are of interest in oncology, neurology, microbiology, immunology, and genetics. The PI's track record has shown these fundamental chemical studies, initially motivated only by scientific curiosity, to inevitably produce new leads of considerable pharmaceutical potential. Research in the next cycle of funding will focus on: (a) thiopeptide antibiotics (genetic modulators and inhibitors of protein synthesis), especially nosiheptide. This effort relies on methodology devised in this lab for the expeditious assembly of the pyridine-thiazole cluster found at the core of the target molecules, and on other techniques developed specifically in response to chemical problems associated with a synthesis of this class of molecules. (b) Methodology for the stereocontrolled creation of 1,2-diamines and its use in an approach to thiostrepton and saframycinoids. The synthesis of these challenging molecules should thus be greatly simplified. (c) Techniques for the stereocontrolled formation of azaspiro centers and application to tetrodotoxin (structurally complex neurotoxic agent that acts as a Na channel blocker), himandrine, and Amaryllidaceae alkaloids. (d) Routes to quinocarcin and cyanocyclin (antitumor agents) via Ugi reactions of aminoacids with aromatic aldehydes. (e) Avenues to mitomycinoids via silylaziridine fragmentation and aza-Payne rearrangement.
Program
Discovery Grants Program - Individual
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
311741-2010
Name nom
Ciufolini, Marco
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2010
Award amount
105000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Partie
5
Nb partie
5
Application title
Synthesis of complex natural products
Keyword
NSERC
Application summary
This research aims to develop innovative, efficient, and environmentally responsible methods for the preparation of nitrogenous substances of current biomedical interest, and apply such techniques to the synthesis of structurally complex natural products. The underlying theme of this research is that certain transformations that had been regarded as unlikely - or even impossible - are quite feasible. Not only they may be incorporated in the total synthesis of complex natural products at an early stage, but they also permit quantum improvements in the overall route. This constitutes the chemical significance of the work. In terms of practical significance, our targets are of interest in oncology, neurology, microbiology, immunology, and genetics. The PI's track record has shown these fundamental chemical studies, initially motivated only by scientific curiosity, to inevitably produce new leads of considerable pharmaceutical potential. Research in the next cycle of funding will focus on: (a) thiopeptide antibiotics (genetic modulators and inhibitors of protein synthesis), especially nosiheptide. This effort relies on methodology devised in this lab for the expeditious assembly of the pyridine-thiazole cluster found at the core of the target molecules, and on other techniques developed specifically in response to chemical problems associated with a synthesis of this class of molecules. (b) Methodology for the stereocontrolled creation of 1,2-diamines and its use in an approach to thiostrepton and saframycinoids. The synthesis of these challenging molecules should thus be greatly simplified. (c) Techniques for the stereocontrolled formation of azaspiro centers and application to tetrodotoxin (structurally complex neurotoxic agent that acts as a Na channel blocker), himandrine, and Amaryllidaceae alkaloids. (d) Routes to quinocarcin and cyanocyclin (antitumor agents) via Ugi reactions of aminoacids with aromatic aldehydes. (e) Avenues to mitomycinoids via silylaziridine fragmentation and aza-Payne rearrangement.
University of British Columbia - $105,000 Grant (2014… | Canada Spends